Navigation Links
Cancer Drug Safe for Late-Stage Pelvic Disease
Date:4/7/2010

Vorinostat can be used with radiotherapy in palliative care, study finds

WEDNESDAY, April 7 (HealthDay News) -- It's safe to use a new oral anti-cancer drug called vorinostat with short-term palliative radiation therapy in patients with advanced pelvic cancer, according to a phase 1 study.

Palliative therapy is used to help control symptoms in patients who can't be cured.

Radiation therapy is an effective palliative treatment to control pain and bleeding in patients with advanced pelvic cancer who aren't eligible for curative radiation therapy or surgery. Vorinostat -- a type of histone deacetylase (HDAC) inhibitor -- is believed to stop tumor growth by altering the expression of several genes necessary for cancer growth.

This study included 16 patients who received either 100 milligram, 200 mg, 300 mg, or 400 mg daily doses of vorinostat three hours before pelvic palliative radiation to 30 Gy in 3 Gy daily fractions over two weeks.

Nausea, diarrhea and anorexia were the most common side effects experienced by all the patients. Biological activity of vorinostat was detected in patients who received the lowest and highest levels of the drug. Most patients had an overall decrease in tumor size six weeks after they completed the combined treatment.

"These observations show that vorinostat can be safely combined with a standard palliative radiotherapy regimen to treat advanced pelvic cancer," wrote Prof. Anne H. Ree of Norwegian Radium Hospital in Oslo and colleagues.

"This study adds to mounting evidence supporting the use of HDAC inhibition in cancer therapy. These data encourage further examination of this class of molecularly targeted agents in clinical radiotherapy," they concluded.

The study was published online April 6 in The Lancet Oncology.

More information

The U.S. National Institutes of Health has more on palliative care.



-- Robert Preidt



SOURCE: The Lancet Oncology, news release, April 6, 2010


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. New study implicates health care utilization, over biology, in colorectal cancer disparities
2. Mount Sinai study finds only a weak link between fruit and vegetable and reduced risk of cancer
3. Fruits, Veggies Have Modest Effect on Cancer Risk
4. Gene Mutations Up Risk for Cancer in Opposite Breast
5. Childhood cancer survivors may face shortened lifespan, study reveals
6. New pyrimidine compounds may lead to improved treatments for childhood brain cancer
7. Breast cancer patients with BRCA mutations 4 times more likely to get cancer in opposite breast
8. Childhood Cancer Survivors At Higher Odds of Early Death
9. Only women with Western Swedish breast cancer gene run higher risk of ovarian cancer
10. New investigation supports correlation between XMRV and prostate cancer
11. New Breast Cancer Book Offers Humor Filled Look at Being Thirty-Something, Single And Getting Through Diagnosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2016)... , ... May 28, 2016 , ... After a year and a half of planning ... an extraordinary event. The Multiple Pathways of Recovery Conference was held May 2 -4, ... country and the United Kingdom came together to explore the many pathways individuals use to ...
(Date:5/27/2016)... ... May 27, 2016 , ... W.S. Badger Co. Inc ... that it has been recognized as one of the best small businesses for new ... as one of nine small businesses providing progressive benefits to new parents on the ...
(Date:5/27/2016)... ... May 27, 2016 , ... In response ... many who are unaware of the plight of aphasia. In collaboration with the ... “Stroke Awareness” campaign. , The link between stroke and aphasia is relatively unknown, ...
(Date:5/27/2016)... ... May 27, 2016 , ... With a team of ... food industries. Aside from its GMP accreditation, Validation Center is also a registered ... products, services and staff. , Validation Center is ISO17025 accredited and only offers ...
(Date:5/26/2016)... ... 26, 2016 , ... Intalere, the healthcare industry leader in ... inaugural Member Conference at the Paris Hotel in Las Vegas, Nev., May 17-20, ... America’s healthcare providers. , The conference was highlighted by the announcement of the ...
Breaking Medicine News(10 mins):
(Date:5/27/2016)... Amarantus BioScience Holdings, Inc. ... Regenerative Medicine, Neurology and Orphan Diseases, today announced that President & ... upcoming investor conferences: SeeThru Equity MicroCap Conference   ... New York City , NY When: Tuesday, May ... Conference   Where: Grand Hyatt Hotel, 109 East 42 ...
(Date:5/26/2016)... NASHVILLE, Tenn. , May 26, 2016 ... provider of software and analytics, network solutions ... healthcare, today announced it entered into a ... leading provider of outpatient software solutions and ... surgery centers, specialty hospitals and rehabilitation clinics ...
(Date:5/25/2016)... , Germany and GERMANTOWN, ... QIAGEN N.V. (NASDAQ: QGEN ; Frankfurt Prime Standard: ... licensing and co-development agreement with Therawis Diagnostics GmbH to develop ... be to develop and market PITX2 as a marker to ... high-risk breast cancer patients. "We are pleased to ...
Breaking Medicine Technology: